EGFR and malignant peripheral nerve sheath tumor: Thus, theoverexpression of EGFR in 95% of NF1 patients with MPNST and the very poorprognosis of these young patients shown in the present study suggest that newtherapies targeting EGFR might be interesting for these patients.